Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: LarryS who wrote (7672)	11/6/1998 1:16:00 PM
From: Robert K.	Respond to of 17367

Way too early for champagne. Stock will go up stock will go down but science is going on.

To: LarryS who wrote (7672)	11/6/1998 2:30:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Larry, I can no longer get this site to work. They just merged the two U.K. public health sites and now I get nothing. Can't even e-mail them to tell them what I think. There were pdf files on mortality which I was gearing up to look at. phls.co.uk Mortality in the U.K. for meningococcemia compared to prior periods would have been a great indicator on what is going on with the trials. This information has been seen by some and depending on ones ability to tweak it and eliminate locations where trials not in progress something of value would have been learned. difficult to imagine, investing millions in a stock without at least seeing this information. That is unless you are bluegreen or Mirthie'e ex neighbor.